[
    "{\"step_by_step_thinking\": \"To determine if therapeutic levels of Vedolizumab can be found in the breast milk of nursing mothers following treatment for Inflammatory bowel disease, we need to consider the pharmacokinetics of the drug. Vedolizumab is a monoclonal antibody that targets integrin receptors in the gut, and it is used to treat Inflammatory bowel disease. It is a large molecule that is unlikely to pass into breast milk in significant amounts. However, to be certain, we need to review available studies or data on the presence of Vedolizumab in breast milk.\", \"answer_choice\": \"B\"}"
]